Cogent Biosciences
COGT
COGT
304 hedge funds and large institutions have $7.17B invested in Cogent Biosciences in 2026 Q1 according to their latest regulatory filings, with 79 funds opening new positions, 116 increasing their positions, 82 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 267 → 304 (+37)
7.47% less ownership
Funds ownership: 122.27% → 114.8% (-7.5%)
12% less funds holding in top 10
Funds holding in top 10: 25 → 22 (-3)
Holders
304
Holding in Top 10
22
Calls
$36.3M
Puts
$27M
Top Buyers
| 1 | +$113M | |
| 2 | +$101M | |
| 3 | +$68.1M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
+$62.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$52.7M |
Top Sellers
| 1 | -$129M | |
| 2 | -$78.8M | |
| 3 | -$78.7M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$78.6M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$73M |
